Gnk Ganesh

Gnk Ganesh

Auto-generated profile, based on publicly available information

Gnk Ganesh

Department of Pharmaceutics, C-NEST, JSS College of Pharmacy

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2009 in Asian Journal of Pharmaceutics
Verified
Journal Article
Closed access
PDF file
RSRaman Sureshkumar
Raman Sureshkumar
MUMunikumar
Munikumar
GGG N K Ganesh
G N K Ganesh
NJN Jawahar
N Jawahar
NDNAGASAMY VENKATESH DHANDAPANI
NAGASAMY VENKATESH DHANDAPANI
MSMk Samantha
Mk Samantha
High molecular weight hydroxypropyl methylcellulose (HPMC) and biodegradable pectin were used for coating the pellets containing curcumin, to be released in the colon. The prepared pellets were free flowing. in vitro release of curcumin remained intact up to pH 3.0, disintegrated at pH 7.2, and released up to 12 hours. The ideal batch (1:3) showed minimum release at pH 1.2 and maximum release at pH 6.8, and an increased amount of curcumin in the blood stream(1.287 ?g/ml) was achieved when compared with pure curcumin (0.5 ?g/ml). The drug release was retarded by the high concentration and greater thickness of the coating of HPMC on the pellets. Release kinetics of the preparation shows a non-Fickian or anamolous diffusion or matrix erosion.

6 February 2026 in Journal of Liposome Research
Verified
Journal Article
Closed access
AMAnishiya Michael
Anishiya Michael
DBDisha Bhattacharya
Disha Bhattacharya
VGVigneshwaran Gopal
Vigneshwaran Gopal
DSDhanushya Suresh
Dhanushya Suresh
JAJana Arun
Jana Arun
GGG. N. K. Ganesh
G. N. K. Ganesh
Liposomes are vesicular carriers and highly engineered multifunctional platforms that can address the broadest range of therapeutic needs. So far, their capacity to encapsulate the hydrophobic and hydrophilic components, as well as their ability to vary their surface chemistry and biocompatibility, has enabled their use on a large scale in oncology, infectious diseases, vaccine delivery, and gene therapy. New developments focus on surface engineering to enhance targeting, stimuli-responsive and intelligent liposome engineering to achieve site-specific drug delivery, and incorporation into hybrid nanocarrier systems that build on and leverage the advantages of multiple delivery platforms. A further expansion in clinical application has been the use of co-delivery and combination therapy approaches, which permit synergistic treatment regimens. Innovations in route-specific delivery, such as inhalable, transdermal, and intranasal liposomal delivery systems or expanded therapeutic delivery and patient adherence. The introduction of individualized and precision liposomal therapy through molecular characterization is a step in the right direction toward individualized treatment regimens. Liposomal medicines have been widely and commercially successful, and liposomal drugs have been approved by the FDA many times (and large-scale production, maximization of stability, regulatory uniformity, and uniform clinical translation are also now no longer problematic). The review provides a combined consideration of the current trend, new technology development, and market awareness with a prospective opportunity description of integrating liposomal delivery with new diagnostic and adaptive therapeutic approaches. Therefore, liposomes will keep leading the pack of forthcoming drug delivery methods as they silence a broader nanotechnology breakthrough through adopting patient-centric approaches.

7 March 2024 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
LSLokeswar Sekar
Lokeswar Sekar
RSRaagul Seenivasan
Raagul Seenivasan
MRM. Vivek Reddy
M. Vivek Reddy
KVK. Dileep Varma
K. Dileep Varma
SASyed Suhaib Ahmed
Syed Suhaib Ahmed
GGGnk Ganesh
Gnk Ganesh
Microneedle-based transdermal medication administration is a revolutionary drug delivery technique that has advantages over parenteral and oral drug delivery systems. They are convenient, painless, safe, and effective. Due to the skin’s stratum corneum layer, the majority of drugs only have a limited impact, which constitutes a thickness of about 10 to 15 µm and acts as a barrier for molecules to reach the site of action, allowing just a few molecules to pass through. To overcome this, many researchers have concentrated on using microneedles to bypass the stratum corneum barrier. The main goal of microneedles is to get the drug into the epidermis without disrupting nerve endings. Micron-sized channels created by the skin layer being broken by microneedles transport the medication directly to the epidermis or higher dermis, avoiding the barrier layer and into the systemic circulation. As a result, the microneedle can improve transdermal drug delivery. Microneedles are fabricated in different forms, such as “Solid Microneedles,” “Coated Microneedles,” “Dissolving or Biodegradable Microneedles,” “Hollow Microneedles” and Hydrogel-forming Microneedles, through the use of components including polymers, polysaccharides, silicon, and metals. Micromolding, laser cutting, dip coating, 3D printing and its techniques are just a few of the processes used to make microneedles. Recently, microneedles have become popular for delivering drugs, genes, proteins, RNA and vaccines, demonstrating significant therapeutic effects. A variety of nano-carriers, along with different delivery methods, assist in emphasizing the use of microneedles in the meantime.

1 May 2026 in Advancements in Life Sciences
Verified
Journal Article
Closed access
GSGuldana Shoinbayeva
Guldana Shoinbayeva
BSBayan Sagindykova
Bayan Sagindykova
SISaltanat Imanalieva
Saltanat Imanalieva
GGGnk Ganesh
Gnk Ganesh
DTDithu Thekkekkara
Dithu Thekkekkara
SCSaravana Babu Chidambaram
Saravana Babu Chidambaram
Background: Salvia deserta Schangin (the Tartarian sage) is one of the little-studied species of the genus Salvia, despite the broad spectrum of biological activity of other representatives of this genus. The plant is common in Central Asia and is traditionally used in folk medicine, but its pharmacological properties have not yet been systematically investigated. The aim of the work was to experimentally study the pharmacological properties of the lyophilized extract of Salvia deserta Schangin, including the assessment of acute oral toxicity and analgesic, anti-inflammatory, and antioxidant activity.Methods: The extract was obtained by ultrasonic extraction followed by lyophilization. Acute toxicity was determined according to OECD Guidelines No. 423. Analgesic activity was determined through the acetic acid writhing test in mice, and anti-inflammatory activity was tested in a model of carrageenan-induced paw edema in rats. Antioxidant properties were assessed using the DPPH and FRAP methods.Results: The lyophilic extract of Salvia deserta Schangin showed low acute toxicity (LD??> 2,000 mg/kg), a pronounced analgesic effect comparable to that of diclofenac sodium, and a significant anti-inflammatory effect at a dose of 400 mg/kg. In DPPH and FRAP tests, the extract showed high antioxidant activity (EC?? = 11.85 ?g/ml; IC?? = 10.4399 ?g/ml).Conclusion: The obtained results demonstrate the strong pharmacological effects of the Tartarian sage and prove it to be a promising source of biologically active compounds with analgesic, anti-inflammatory, and antioxidant properties. The study presents the first comprehensive assessment of the pharmacological activity of the lyophilized extract of Salvia deserta Schangin, which gives grounds to consider this species as a new promising object for the development of phytopreparations.Keywords: Tartarian sage, Antinociceptive activity, Anti-inflammatory activity, Medicinal plant raw materials

19 May 2022 in Vitae
Verified
Journal Article
Open access
PDF file
HVHari V
Hari V
GGGnk Ganesh
Gnk Ganesh
VMVivek Reddy M
Vivek Reddy M
SASyed Suhaib Ahmed
Syed Suhaib Ahmed
BACKGROUND: COVID-19 pandemic situation made the pharmaceutical companies develop the vaccine with different formulations in a short period. OBJECTIVES: The main objective of the review is to focus on different types of vaccine formulations available globally and the importance of technology transfer in vaccine development associated with potential risks. RESULTS: Research on vaccine development led to various types of vaccines, such as Inactivated vaccines, live attenuated vaccines, Ribonucleic acid (RNA) and Deoxyribonucleic acid (DNA) vaccines, viral vector vaccines, and Protein Subunit Vaccines for COVID-19. But the process of vaccine development and technology transfer is lined with various risks and challenges. Through risk assessment, we found some major potential risks involved in product development; this leads to a smoother and more efficient method to develop safe vaccines available for public health. CONCLUSIONS: This review will explain the significance of technology collaboration for the faster development of various formulations of vaccines globally.